Sabater AL - Search Results

1

Living with Dry Eye Disease and its Effects on Quality of Life: Patient, Optometrist, and Ophthalmologist Perspectives.

Tovar AA, Frankel ST, Galor A, Sabater AL. Tovar AA, et al. Among authors: sabater al. Ophthalmol Ther. 2023 Oct;12(5):2219-2226. doi: 10.1007/s40123-023-00736-7. Epub 2023 Jun 16. Ophthalmol Ther. 2023. PMID: 37328618 Free PMC article.

2

Novel treatments for dry eye syndrome.

Roucaute E, Huertas-Bello M, Sabater AL. Roucaute E, et al. Among authors: sabater al. Curr Opin Pharmacol. 2024 Apr;75:102431. doi: 10.1016/j.coph.2024.102431. Epub 2024 Jan 25. Curr Opin Pharmacol. 2024. PMID: 38277944 Review.

3

Neurotrophic Keratopathy After Slow Coagulation Transscleral Cyclophotocoagulation.

Sayed MS, Khodeiry MM, Elhusseiny AM, Sabater AL, Lee RK. Sayed MS, et al. Among authors: sabater al. Cornea. 2023 Dec 1;42(12):1582-1585. doi: 10.1097/ICO.0000000000003325. Epub 2023 Aug 1. Cornea. 2023. PMID: 37535806

4

Ocular Gene Therapy in a Patient with Dystrophic Epidermolysis Bullosa.

Tovar Vetencourt A, Sayed-Ahmed I, Gomez J, Chen H, Agostini B, Carroll K, Parry T, Krishnan S, Sabater AL. Tovar Vetencourt A, et al. Among authors: sabater al. N Engl J Med. 2024 Feb 8;390(6):530-535. doi: 10.1056/NEJMoa2301244. N Engl J Med. 2024. PMID: 38324486

5

Comparison of Transcriptomic Analysis of the Conjunctiva in Glaucoma-Treated Eyes with Dry Eyes and Healthy Controls.

Carnero E, Irigoyen-Bañegil C, Gutiérrez I, Extramiana L, Sabater AL, Moreno-Montañes J. Carnero E, et al. Among authors: sabater al. Biomolecules. 2023 Dec 25;14(1):30. doi: 10.3390/biom14010030. Biomolecules. 2023. PMID: 38254630 Free PMC article.

6

Efficacy of plasma rich in growth factors (PRGF) in stage 1 neurotrophic keratitis.

Ghalibafan S, Osei KA, Amescua G, Sabater AL. Ghalibafan S, et al. Among authors: sabater al. Eye (Lond). 2024 May;38(7):1390-1391. doi: 10.1038/s41433-023-02904-2. Epub 2023 Dec 30. Eye (Lond). 2024. PMID: 38160214 No abstract available.

7

Ocular surface changes associated with belantamab mafodotin treatment.

Ghalibafan S, Osei KA, Hoffman JE, Sabater AL. Ghalibafan S, et al. Among authors: sabater al. Graefes Arch Clin Exp Ophthalmol. 2023 Nov;261(11):3201-3204. doi: 10.1007/s00417-023-06094-1. Epub 2023 May 22. Graefes Arch Clin Exp Ophthalmol. 2023. PMID: 37212873 No abstract available.

8

Fluorescein CorneoGraphy (FCG): Use of a repurposed fluorescein imaging technique to objectively standardize corneal staining.

Soifer M, Azar NS, Blanco R, Mousa HM, Ghalibafan S, Tovar A, Mettu PS, Allingham MJ, Cousins SW, Sabater AL, Perez VL. Soifer M, et al. Among authors: sabater al. Ocul Surf. 2023 Jan;27:77-79. doi: 10.1016/j.jtos.2022.11.010. Epub 2022 Dec 2. Ocul Surf. 2023. PMID: 36464234 Free PMC article.

9

Intraocular inflammasome signalling in failed corneal transplants.

Serrano A, Gomez-Bedoya A, Tovar AA, Huertas-Bello M, Amescua G, Koo EH, Cabot F, Hadad R, Dubovy SR, de Rivero Vaccari JP, Sabater AL. Serrano A, et al. Among authors: sabater al. Eye (Lond). 2023 Mar;37(4):787-789. doi: 10.1038/s41433-022-02236-7. Epub 2022 Sep 12. Eye (Lond). 2023. PMID: 36097064 Free PMC article. No abstract available.

10

Establishment of a bi-layered tissue engineered conjunctiva using a 3D-printed melt electrowritten poly-(ε-caprolactone) scaffold.

Xie J, Gao Q, Del Prado ZN, Venkateswaran N, Mousa HM, Salero E, Ye J, De Juan-Pardo EM, Sabater AL, Perez VL. Xie J, et al. Among authors: sabater al. Int Ophthalmol. 2023 Jan;43(1):215-232. doi: 10.1007/s10792-022-02418-y. Epub 2022 Aug 6. Int Ophthalmol. 2023. PMID: 35932420 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

47 results

Search Page